Approval · Notice of Compliance 19469 · 2017
BANAMINE: Notice of Compliance 19469
Issued June 28, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19469
- Date
- June 28, 2017
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BANAMINE | 02457180 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 83 MG per ML